Cleveland Clinic Journal of Medicine Impact Factor & Information

Publisher: Cleveland Clinic Foundation; Cleveland Clinic Educational Foundation

Current impact factor: 2.71

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 2.712
2013 Impact Factor 3.37
2012 Impact Factor 3.4
2011 Impact Factor 3.773
2010 Impact Factor 3.495
2009 Impact Factor 2.149
2008 Impact Factor 1.969
2007 Impact Factor 1.312
2006 Impact Factor 1.179
2005 Impact Factor 1.142
2004 Impact Factor 1.095
2003 Impact Factor 0.885
2002 Impact Factor 0.722
2001 Impact Factor 0.788
2000 Impact Factor 0.827
1999 Impact Factor 0.367
1998 Impact Factor 0.41
1997 Impact Factor 0.51
1996 Impact Factor 0.353
1995 Impact Factor 0.344
1994 Impact Factor 0.279
1993 Impact Factor 0.178
1992 Impact Factor 0.293

Impact factor over time

Impact factor

Additional details

5-year impact 3.59
Cited half-life 6.40
Immediacy index 0.70
Eigenfactor 0.00
Article influence 1.20
Other titles Cleveland Clinic journal of medicine (Online), Cleveland Clinic journal of medicine
ISSN 1939-2869
OCLC 55985916
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: Learning disabilities are common and can negatively affect the individual and, ultimately, society. Pediatricians should be able to identify the risk factors for learning disabilities, recognize the early warning signs, and apply the appropriate diagnostic tools. Pediatricians also can play a crucial role by encouraging schools to provide accommodations for the child, requesting multifactorial evaluations from the school district, and referring patients for detailed neuropsychological evaluation outside the school district when appropriate. Information from the pediatrician can help the school formulate an individualized education plan for the child. Additionally, the primary care pediatrician can support families with referrals to appropriate healthcare specialists.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11 Suppl 1):S24-S28. DOI:10.3949/ccjm.82.s1.05
  • [Show abstract] [Hide abstract]
    ABSTRACT: Long-acting reversible contraceptives (LARCs) are safe for use in adolescents and do not rely on compliance or adherence for effectiveness. Continuation rates are higher and pregnancy rates are lower for adolescent users of LARCs compared with short-acting methods such as oral contraceptives. Similarly, repeat pregnancy rates are lower when LARCs are used compared with other forms of contraception. Myths and misconceptions about LARCs and other contraceptives remain a barrier to their use. Health care providers are in a unique position to provide confidential care to adolescents, and should provide education to them about the various contraceptive options, especially LARCs.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11 Suppl 1):S8-S12. DOI:10.3949/ccjm.82.s1.02
  • [Show abstract] [Hide abstract]
    ABSTRACT: Advances have been made in understanding and treating both common and rare dermatologic conditions. Atopic dermatitis benefits from bathing and ceramide moisturizers. Common allergic contact dermatitis may have specific presentations. Tinea capitis is effectively treated with terbinafine. Infantile hemangiomas should be treated early in the disease course and respond well to propranolol; any white sign of ulceration should be noted. Localized alopecia areata responds well to topical clobetasol, avoiding the need for intralesional injections. Topical rapamycin can be used to treat tuberous sclerosis. Further understanding of genetics will help guide pediatricians to the proper diagnosis and treatment of skin conditions.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11 Suppl 1):S19-S23. DOI:10.3949/ccjm.82.s1.04
  • [Show abstract] [Hide abstract]
    ABSTRACT: Screening and surveillance are crucial components to the early detection of developmental disorders in children, which enables early interventions that provide the best chances for improved outcomes. Identifying a developmental disorder is the initial step in evaluating the disorder. Surveillance is a flexible, continuous, longitudinal process aimed at identifying concerns, and it should be performed at every well-child visit. Screening involves administering a brief, standardized tool normalized for specific ages and stages of development to identify any developmental delays or specific concerns such as autism. Screening is recommended at every office visit and whenever a parent expresses a concern. Two general types of screening tests are available: problem-specific screening and broadband developmental screening. For each type, there are multiple different tests available that can be administered by a parent or a health care provider. Factors to consider in the test selection are the age range for which it is intended, time it takes to complete and score, cost, whether the test is paper-based or electronic, and the language availability.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11 Suppl 1):S29-S32. DOI:10.3949/ccjm.82.s1.06
  • [Show abstract] [Hide abstract]
    ABSTRACT: Behavioral disorders in pediatric patients--primarily attention deficit hyperactivity disorder (ADHD)--pose a clinical challenge for health care providers to accurately assess, diagnose, and treat. In 2013, updated diagnostic criteria for behavioral disorders were published, including ADHD and a new diagnostic entity: disruptive mood dysregulation disorder. Revised criteria for ADHD includes oldest age for occurrence of symptoms, need for symptoms to be present in more than one setting, and requirement for number of symptoms in those aged 17 and older. Assessment of ADHD relies primarily on the clinical interview, including the medical and social history, along with the aid of objective measures. The clinical course of ADHD is chronic with symptom onset occurring well before adolescence. Most patients have symptoms that continue into adolescence, and some into adulthood. Many patients with ADHD have comorbid disorders such as depression, disruptive behavior disorders, or substance abuse, which need to be addressed first in the treatment plan. Treatment of ADHD relies on a combination of psychopharmacologic, academic, and behavioral interventions, which produce response rates up to 80%.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11 Suppl 1):S2-S7. DOI:10.3949/ccjm.82.s1.01
  • [Show abstract] [Hide abstract]
    ABSTRACT: Respiratory syncytial virus (RSV) is one of the most common lower respiratory disease in infants and young children worldwide. Despite its long history, a safe and effective cure for RSV remains elusive. Nonetheless, further understanding of RSV pathogenesis and risk factors have led to advances in prophylaxis and management. The leading risk factor for RSV is premature birth, primarily because fewer protective antibodies are transmitted from the mother to the infant. For full-term born infants, susceptibility to RSV increases as maternal IgG titers decline to a nadir at 2 to 3 months of age. Because of the unique pathophysiologic mechanisms involved in this infection, it is likely that future treatment strategies will focus on modulating the host immune response to the virus, rather than virucidal or virustatic molecules.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11 Suppl 1):S13-S18. DOI:10.3949/ccjm.82.s1.03

  • Cleveland Clinic Journal of Medicine 11/2015; 82(11):719-720. DOI:10.3949/ccjm.82a.14176
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cannabis is widely used for a variety of reasons, and its changing legal status may foster more new users. Although the acute clinical effects of cannabis are generally benign, clinicians should be aware of health complications and testing limitations.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11):765-772. DOI:10.3949/ccjm.82a.14073
  • [Show abstract] [Hide abstract]
    ABSTRACT: Major improvements in the care of liver transplant recipients have mitigated but not eliminated the risk of potentially life-threatening infectious complications. This review provides general information about risk factors, prophylactic strategies, diagnostic workup, and therapy for some of the most commonly encountered infections after liver transplant.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11):773-784. DOI:10.3949/ccjm.82a.14118

  • Cleveland Clinic Journal of Medicine 11/2015; 82(11):721-722. DOI:10.3949/ccjm.82a.14119
  • [Show abstract] [Hide abstract]
    ABSTRACT: Botulinum toxin has several noncosmetic uses in otolaryngology. It is the primary treatment for spasmodic dysphonia and may be effective in select patients who have essential tremor of the voice. It may also be used to treat swallowing difficulties caused by cricopharyngeal dysfunction.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11):729-732. DOI:10.3949/ccjm.82a.14096
  • [Show abstract] [Hide abstract]
    ABSTRACT: Pancreas transplant is an option for patients with type 1 diabetes and for some patients with type 2 diabetes and advanced diabetic kidney disease. The procedure has a high success rate, and performing it earlier in the course of diabetes could help prevent or reverse the long-term complications of diabetes.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11):738-744. DOI:10.3949/ccjm.82a.14090
  • [Show abstract] [Hide abstract]
    ABSTRACT: The field of women's health is varied and dynamic. Major studies in 2014 and the first half of 2015 suggest that selective serotonin reuptake inhibitors are not strongly associated with congenital heart defects, that paroxetine 7.5 mg is effective for treating menopausal symptoms, and that women with heart failure may benefit more from cardiac resynchronization therapy than men.
    Cleveland Clinic Journal of Medicine 11/2015; 82(11):759-764. DOI:10.3949/ccjm.82a.15096

  • Cleveland Clinic Journal of Medicine 11/2015; 82(11):714. DOI:10.3949/ccjm.82b.11015

  • Cleveland Clinic Journal of Medicine 11/2015; 82(11):716-718. DOI:10.3949/ccjm.82a.15038
  • [Show abstract] [Hide abstract]
    ABSTRACT: The PARADIGM-HF trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) found a combination drug containing sacubitril (a neprilysin inhibitor) and valsartan (an angiotensin II receptor blocker) superior to enalapril (an angiotensin-converting enzyme inhibitor) in patients with systolic heart failure. Recently approved by the US Food and Drug Administration, sacubitril-valsartan is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.
    Cleveland Clinic Journal of Medicine 10/2015; 82(10):693-701. DOI:10.3949/ccjm.82a.14163

  • Cleveland Clinic Journal of Medicine 10/2015; 82(10):702-704. DOI:10.3949/ccjm.82a.15121

  • Cleveland Clinic Journal of Medicine 10/2015; 82(10):633. DOI:10.3949/ccjm.82b.10015